Last reviewed · How we verify
GLPG0974
At a glance
| Generic name | GLPG0974 |
|---|---|
| Sponsor | Galapagos NV |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis (PHASE2)
- Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects (PHASE1)
- First-in-Human Exploratory Single Ascending Dose of GLPG0974 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |